Phase 2

Phase 2b Study of GSK4532990 in Adults With NASH

Sponsor:

GlaxoSmithKline

Code:

NCT05583344

Conditions

Nonalcoholic Fatty Liver Disease

Non-alcoholic Fatty Liver Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

GSK4532990

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information